Martin Martinov's Contact Details

Martin Martinov's Company Details

FAR Biotech

, , • 1 - 10 Employees
Biotechnology

FAR Biotech is an in silico drug discovery platform company that can reliably, quickly and cost-effectively identify novel drug-like molecules against any therapeutic target.By incorporating quantum mechanical modeling of biomolecular interactions, machine learning, and big data computational techniques, our proprietary technology yields optimized lead molecules that, beyond being bioactive against the target, also possess favorable drug-like attributes (molecular weight, ADME-Tox, etc.)Our target-agnostic technology has been validated across a broad range of therapeutic indications, including oncology, neurodegenerative conditions and infectious diseases.We employ a hybrid business model that involves i) development of internal, pre-clinical assets with outsourced experimental testing; and ii) "fee for service" collaborations with industry and academic partners to refine and optimize drug leads. FAR Biotech was founded in late 2016 by Dr. Martin Martinov and owns proprietary technology that has been developed and refined over the last 25 years (60+ person-years of total R&D including collaborators).